HIF1A and metabolic dysfunction-associated steatotic liver disease: In the current study, we demonstrated that pharmacological activation of HIF-1 and genetic forced intestine HIF-1 overexpression protects against western diet–induced MASLD and was associated with reduced systemic inflammatory response and hepatic bacterial translocation.